<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20250115151115&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;ff=20250115151115&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 15 Jan 2025 20:11:16 +0000</lastbuilddate>
<pubDate>Wed, 15 Jan 2025 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Artificial Intelligence-Guided Lung Ultrasound by Nonexperts</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39813064/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: In this multicenter validation study, THCPs with AI assistance achieved LUS images meeting diagnostic standards compared with LUS experts without AI. This technology could extend access to LUS to underserved areas lacking expert personnel.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Jan 15. doi: 10.1001/jamacardio.2024.4991. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Lung ultrasound (LUS) aids in the diagnosis of patients with dyspnea, including those with cardiogenic pulmonary edema, but requires technical proficiency for image acquisition. Previous research has demonstrated the effectiveness of artificial intelligence (AI) in guiding novice users to acquire high-quality cardiac ultrasound images, suggesting its potential for broader use in LUS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To evaluate the ability of AI to guide acquisition of diagnostic-quality LUS images by trained health care professionals (THCPs).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: In this multicenter diagnostic validation study conducted between July 2023 and December 2023, participants aged 21 years or older with shortness of breath recruited from 4 clinical sites underwent 2 ultrasound examinations: 1 examination by a THCP operator using Lung Guidance AI and the other by a trained LUS expert without AI. The THCPs (including medical assistants, respiratory therapists, and nurses) underwent standardized AI training for LUS acquisition before participation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTIONS: Lung Guidance AI software uses deep learning algorithms guiding LUS image acquisition and B-line annotation. Using an 8-zone LUS protocol, the AI software automatically captures images of diagnostic quality.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: The primary end point was the proportion of THCP-acquired examinations of diagnostic quality according to a panel of 5 masked expert LUS readers, who provided remote review and ground truth validation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The intention-to-treat analysis included 176 participants (81 female participants [46.0%]; mean [SD] age, 63 [14] years; mean [SD] body mass index, 31 [8]). Overall, 98.3% (95% CI, 95.1%-99.4%) of THCP-acquired studies were of diagnostic quality, with no statistically significant difference in quality compared to LUS expert-acquired studies (difference, 1.7%; 95% CI, -1.6% to 5.0%).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: In this multicenter validation study, THCPs with AI assistance achieved LUS images meeting diagnostic standards compared with LUS experts without AI. This technology could extend access to LUS to underserved areas lacking expert personnel.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05992324.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39813064/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39813064</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.4991>10.1001/jamacardio.2024.4991</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39813064</guid>
<pubDate>Wed, 15 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Cristiana Baloescu</dc:creator>
<dc:creator>John Bailitz</dc:creator>
<dc:creator>Baljash Cheema</dc:creator>
<dc:creator>Ravi Agarwala</dc:creator>
<dc:creator>Madeline Jankowski</dc:creator>
<dc:creator>Onyinyechi Eke</dc:creator>
<dc:creator>Rachel Liu</dc:creator>
<dc:creator>Jason Nomura</dc:creator>
<dc:creator>Lori Stolz</dc:creator>
<dc:creator>Luna Gargani</dc:creator>
<dc:creator>Eren Alkan</dc:creator>
<dc:creator>Tyler Wellman</dc:creator>
<dc:creator>Nripesh Parajuli</dc:creator>
<dc:creator>Andrew Marra</dc:creator>
<dc:creator>Yngvil Thomas</dc:creator>
<dc:creator>Daven Patel</dc:creator>
<dc:creator>Evelyn Schraft</dc:creator>
<dc:creator>James O'Brien</dc:creator>
<dc:creator>Christopher L Moore</dc:creator>
<dc:creator>Michael Gottlieb</dc:creator>
<dc:date>2025-01-15</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Artificial Intelligence-Guided Lung Ultrasound by Nonexperts</dc:title>
<dc:identifier>pmid:39813064</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.4991</dc:identifier>
</item>
<item>
<title>Genetic Predisposition to Low-Density Lipoprotein Cholesterol and Incident Type 2 Diabetes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39813027/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: In this cohort study, LDL-C and T2D risks were inversely associated across genetic mechanisms for LDL-C variation. Further elucidation of the mechanisms associating low LDL-C risk with increased risk of T2D is warranted.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Jan 15. doi: 10.1001/jamacardio.2024.5072. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Treatment to lower high levels of low-density lipoprotein cholesterol (LDL-C) reduces incident coronary artery disease (CAD) risk but modestly increases the risk for incident type 2 diabetes (T2D). The extent to which genetic factors across the cholesterol spectrum are associated with incident T2D is not well understood.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To investigate the association of genetic predisposition to increased LDL-C levels with incident T2D risk.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: In this large prospective, population-based cohort study, UK Biobank participants who underwent whole-exome sequencing and genome-wide genotyping were included. Participants were separated into 7 groups with familial hypercholesterolemia (FH), predicted loss of function (pLOF) in APOB or PCSK9 variants, and LDL-C polygenic risk score (PRS) quintiles. Data were collected between 2006 and 2010, with a median follow-up of 13.7 (IQR, 12.9-14.5) years. Data were analyzed from March 1 to November 1, 2024.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: LDL-C level, LDL-C PRS, FH, or pLOF variant status.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Cox proportional hazards regression models adjusted for age, sex, genotyping array, lipid-lowering medication use, and the first 10 genetic principal components were fitted to assess the association between LDL-C genetic factors and incident T2D and CAD risks.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among the 361 082 participants, mean (SD) age was 56.8 (8.0) years, 194 751 (53.9%) were female, and mean (SD) baseline LDL-C level was 138.0 (33.6) mg/dL. During the follow-up period, 22 619 (6.3%) participants developed incident T2D and 17 966 (5.0%) developed incident CAD. The hazard ratio for incident T2D was lowest in the FH group (0.65; 95% CI, 0.54-0.77), while the highest risk was in the pLOF group (1.48; 95% CI, 1.18-1.86). The association between LDL-C PRS and incident T2D was 0.72 (95% CI, 0.66-0.79) for very high LDL-C PRS, 0.87 (95% CI, 0.84-0.90) for high LDL-C PRS, 1.13 (95% CI, 1.09-1.17) for low LDL-C PRS, and 1.26 (95% CI, 1.15-1.38) for very low LDL-C PRS. CAD risk increased directly with the LDL-C PRS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: In this cohort study, LDL-C and T2D risks were inversely associated across genetic mechanisms for LDL-C variation. Further elucidation of the mechanisms associating low LDL-C risk with increased risk of T2D is warranted.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39813027/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39813027</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.5072>10.1001/jamacardio.2024.5072</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39813027</guid>
<pubDate>Wed, 15 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Akshaya Ravi</dc:creator>
<dc:creator>Satoshi Koyama</dc:creator>
<dc:creator>So Mi Jemma Cho</dc:creator>
<dc:creator>Sara Haidermota</dc:creator>
<dc:creator>Whitney Hornsby</dc:creator>
<dc:creator>Patrick T Ellinor</dc:creator>
<dc:creator>Pradeep Natarajan</dc:creator>
<dc:date>2025-01-15</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Genetic Predisposition to Low-Density Lipoprotein Cholesterol and Incident Type 2 Diabetes</dc:title>
<dc:identifier>pmid:39813027</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.5072</dc:identifier>
</item>
<item>
<title>Using artificial intelligence to spot heart failure from ECGs: is it prime time?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39812702/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 15:ehae906. doi: 10.1093/eurheartj/ehae906. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39812702/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39812702</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae906>10.1093/eurheartj/ehae906</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39812702</guid>
<pubDate>Wed, 15 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Charalambos Antoniades</dc:creator>
<dc:creator>Kenneth Chan</dc:creator>
<dc:date>2025-01-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Using artificial intelligence to spot heart failure from ECGs: is it prime time?</dc:title>
<dc:identifier>pmid:39812702</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae906</dc:identifier>
</item>
<item>
<title>Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39811953/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>The use of assisted reproductive technology (ART) is growing, both to assist individuals with infertility and for fertility preservation. Individuals with cardiovascular disease (CVD), or risk factors for CVD, are increasingly using ART. Thus, knowing how to care for patients undergoing ART is important for the cardiovascular clinician. In this scientific statement, we review the ART process and known short-term and long-term risks associated with ART that can adversely affect patients with CVD....</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 15. doi: 10.1161/CIR.0000000000001292. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The use of assisted reproductive technology (ART) is growing, both to assist individuals with infertility and for fertility preservation. Individuals with cardiovascular disease (CVD), or risk factors for CVD, are increasingly using ART. Thus, knowing how to care for patients undergoing ART is important for the cardiovascular clinician. In this scientific statement, we review the ART process and known short-term and long-term risks associated with ART that can adversely affect patients with CVD. We review current knowledge on risks from ART for specific cardiac conditions and provide a suggested approach to evaluating and counseling patients with CVD contemplating ART as well as suggested management before and during the ART process. Individuals with CVD are at increased risk for pregnancy complications, and management of this unique population has been discussed previously. The focus of this scientific statement is on ART. Therefore, discussions on risk assessment, counseling, and management of individuals with CVD during pregnancy are limited, and established guidelines are referenced.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39811953/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39811953</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001292>10.1161/CIR.0000000000001292</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39811953</guid>
<pubDate>Wed, 15 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Rina Mauricio</dc:creator>
<dc:creator>Garima Sharma</dc:creator>
<dc:creator>Jennifer Lewey</dc:creator>
<dc:creator>Rose Tompkins</dc:creator>
<dc:creator>Torie Plowden</dc:creator>
<dc:creator>Kathryn Rexrode</dc:creator>
<dc:creator>Mary Canobbio</dc:creator>
<dc:creator>Jenna Skowronski</dc:creator>
<dc:creator>Afshan Hameed</dc:creator>
<dc:creator>Candice Silversides</dc:creator>
<dc:creator>Harmony Reynolds</dc:creator>
<dc:creator>Arthur Vaught</dc:creator>
<dc:creator>American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Lifelong Congenital Heart Disease and Heart Health in the Young</dc:creator>
<dc:date>2025-01-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:39811953</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001292</dc:identifier>
</item>
<item>
<title>Mind the gap: sex-related differences in cardiovascular disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39810050/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 14. doi: 10.1038/s41569-025-01120-7. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39810050/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39810050</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01120-7>10.1038/s41569-025-01120-7</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39810050</guid>
<pubDate>Tue, 14 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Anju Loveridge</dc:creator>
<dc:date>2025-01-14</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Mind the gap: sex-related differences in cardiovascular disease</dc:title>
<dc:identifier>pmid:39810050</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01120-7</dc:identifier>
</item>
<item>
<title>Engineering extracellular vesicles for therapeutic delivery in ischaemic stroke</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39810049/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 14. doi: 10.1038/s41569-025-01122-5. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39810049/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39810049</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01122-5>10.1038/s41569-025-01122-5</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39810049</guid>
<pubDate>Tue, 14 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Lara Anne Birch</dc:creator>
<dc:date>2025-01-14</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Engineering extracellular vesicles for therapeutic delivery in ischaemic stroke</dc:title>
<dc:identifier>pmid:39810049</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01122-5</dc:identifier>
</item>
<item>
<title>Effective CRISPR modulation of complex non-coding RNA loci</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39810048/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 14. doi: 10.1038/s41569-025-01117-2. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39810048/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39810048</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01117-2>10.1038/s41569-025-01117-2</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39810048</guid>
<pubDate>Tue, 14 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Francesca Vacante</dc:creator>
<dc:creator>Andrew H Baker</dc:creator>
<dc:date>2025-01-14</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Effective CRISPR modulation of complex non-coding RNA loci</dc:title>
<dc:identifier>pmid:39810048</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01117-2</dc:identifier>
</item>
<item>
<title>Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39809303/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Exercise training, especially in-person sessions, was associated with improved HR-QoL, depression and anxiety, independently of exercise type. However, this study raises concern about the effectiveness of home-based programmes in improving these outcomes.Study protocol was registered in PROSPERO (ID: CRD42023402569).</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 15:ehae870. doi: 10.1093/eurheartj/ehae870. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Individuals with coronary artery disease have poorer mental health, health-related quality of life (HR-QoL), and cognition compared with (age-matched) controls. Exercise training may attenuate these effects. The aim is to systematically review and meta-analyse the effects of different exercise types and settings on brain structure/function, cognition, HR-QoL, mental health (e.g. depression, anxiety), and sleep in patients with coronary artery disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A systematic search was conducted and a network meta-analysis compared (i) exercise types, high-intensity interval training (HIIT), HIIT + resistance (HIIT + R), moderate-intensity training (MIT), MIT + R and stretching-toning-balance training, and (ii) exercise settings, in-person and home-based.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 42 randomized controlled trials with a parallel group design were identified, of which 36 were included in the meta-analysis. Few studies included cognition (n = 2), sleep (n = 2), and none brain structure/function (n = 0). Most studies examined HR-QoL (n = 30), depression (n = 15), and anxiety (n = 9), in which outcomes were meta-analysed. HIIT + R, HIIT, and MIT were associated with improved HR-QoL vs. no exercise (i.e. usual care) [standardized mean difference, SMD: 1.53 (95% confidence interval 0.83; 2.24), 0.44 (0.15; 0.73), and 0.44 (0.20; 0.67), respectively]. In-person exercise was associated with larger and significant improvements [HR-QoL SMD: 0.51 (0.28; 0.74), depressive SMD: -0.55 (-1.03; -0.07), and anxiety symptoms SMD: -1.16 (-2.05; -0.26)] compared with no exercise, whereas home-based programmes were not significantly associated with improvements in these outcomes. Findings were robust in secondary (i.e. intervention duration and volume) and sensitivity analyses excluding high risk of bias studies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Exercise training, especially in-person sessions, was associated with improved HR-QoL, depression and anxiety, independently of exercise type. However, this study raises concern about the effectiveness of home-based programmes in improving these outcomes.Study protocol was registered in PROSPERO (ID: CRD42023402569).</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39809303/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39809303</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae870>10.1093/eurheartj/ehae870</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39809303</guid>
<pubDate>Tue, 14 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Angel Toval</dc:creator>
<dc:creator>Esmée A Bakker</dc:creator>
<dc:creator>Joao Bruno Granada-Maia</dc:creator>
<dc:creator>Sergio Núñez de Arenas-Arroyo</dc:creator>
<dc:creator>Patricio Solis-Urra</dc:creator>
<dc:creator>Thijs M H Eijsvogels</dc:creator>
<dc:creator>Irene Esteban-Cornejo</dc:creator>
<dc:creator>Vicente Martínez-Vizcaíno</dc:creator>
<dc:creator>Francisco B Ortega</dc:creator>
<dc:date>2025-01-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Exercise type and settings, quality of life, and mental health in coronary artery disease: a network meta-analysis</dc:title>
<dc:identifier>pmid:39809303</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae870</dc:identifier>
</item>
<item>
<title>ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39808105/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Jan 7:S0735-1097(24)10510-4. doi: 10.1016/j.jacc.2024.11.023. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39808105/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39808105</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.11.023>10.1016/j.jacc.2024.11.023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39808105</guid>
<pubDate>Tue, 14 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Writing Group</dc:creator>
<dc:creator>Andrea M Russo</dc:creator>
<dc:creator>Milind Y Desai</dc:creator>
<dc:creator>Monika M Do</dc:creator>
<dc:creator>Javed Butler</dc:creator>
<dc:creator>Mina K Chung</dc:creator>
<dc:creator>Andrew E Epstein</dc:creator>
<dc:creator>Maya E Guglin</dc:creator>
<dc:creator>Wayne C Levy</dc:creator>
<dc:creator>Jonathan P Piccini</dc:creator>
<dc:creator>Rating Panel</dc:creator>
<dc:creator>Nicole M Bhave</dc:creator>
<dc:creator>Andrea M Russo</dc:creator>
<dc:creator>Milind Y Desai</dc:creator>
<dc:creator>Monika M Do</dc:creator>
<dc:creator>Amrut V Ambardekar</dc:creator>
<dc:creator>Nancy C Berg</dc:creator>
<dc:creator>Kenneth C Bilchick</dc:creator>
<dc:creator>G William Dec</dc:creator>
<dc:creator>Rakesh Gopinathannair</dc:creator>
<dc:creator>Janet K Han</dc:creator>
<dc:creator>Liviu Klein</dc:creator>
<dc:creator>Rachel J Lampert</dc:creator>
<dc:creator>Gurusher S Panjrath</dc:creator>
<dc:creator>Ryan R Reeves</dc:creator>
<dc:creator>Danita Marie Yoerger Sanborn</dc:creator>
<dc:creator>Lynne W Stevenson</dc:creator>
<dc:creator>Quynh A Truong</dc:creator>
<dc:creator>Paul D Varosy</dc:creator>
<dc:creator>Todd C Villines</dc:creator>
<dc:creator>Annabelle S Volgman</dc:creator>
<dc:creator>Karolina M Zareba</dc:creator>
<dc:date>2025-01-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing</dc:title>
<dc:identifier>pmid:39808105</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.11.023</dc:identifier>
</item>
<item>
<title>Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39805949/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>Atherosclerosis is a disease of large and medium arteries that can lead to life-threatening cardiovascular and cerebrovascular consequences, such as myocardial infarction and stroke. Moreover, atherosclerosis is a major contributor to cardiovascular-related mortality in individuals with diabetes mellitus. Diabetes aggravates the pathobiological mechanisms that underlie the development of atherosclerosis. Currently available anti-atherosclerotic drugs or strategies solely focus on optimal control...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 13. doi: 10.1038/s41569-024-01115-w. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Atherosclerosis is a disease of large and medium arteries that can lead to life-threatening cardiovascular and cerebrovascular consequences, such as myocardial infarction and stroke. Moreover, atherosclerosis is a major contributor to cardiovascular-related mortality in individuals with diabetes mellitus. Diabetes aggravates the pathobiological mechanisms that underlie the development of atherosclerosis. Currently available anti-atherosclerotic drugs or strategies solely focus on optimal control of systemic risk factors, including hyperglycaemia and dyslipidaemia, but do not adequately target the diabetes-exacerbated mechanisms of atherosclerotic cardiovascular disease, highlighting the need for targeted, mechanism-based therapies. This Review focuses on emerging pathological mechanisms and related novel therapeutic targets in atherosclerotic cardiovascular disease in patients with diabetes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39805949/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39805949</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01115-w>10.1038/s41569-024-01115-w</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39805949</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Abdul Waheed Khan</dc:creator>
<dc:creator>Karin A M Jandeleit-Dahm</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches</dc:title>
<dc:identifier>pmid:39805949</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01115-w</dc:identifier>
</item>
<item>
<title>Cardiac optogenetics: controlling the heart with light</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39805948/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 13. doi: 10.1038/s41569-025-01119-0. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39805948/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39805948</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01119-0>10.1038/s41569-025-01119-0</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39805948</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Sasha B Forbes</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Cardiac optogenetics: controlling the heart with light</dc:title>
<dc:identifier>pmid:39805948</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01119-0</dc:identifier>
</item>
<item>
<title>Cardiac Plasticity in Hypertrophic Cardiomyopathy: Exercise as Medicine?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804911/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):145-148. doi: 10.1161/CIRCULATIONAHA.124.072649. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804911/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804911</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072649>10.1161/CIRCULATIONAHA.124.072649</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804911</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>James P MacNamara</dc:creator>
<dc:creator>Michael P Ayers</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Cardiac Plasticity in Hypertrophic Cardiomyopathy: Exercise as Medicine?</dc:title>
<dc:identifier>pmid:39804911</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072649</dc:identifier>
</item>
<item>
<title>Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804910/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):e22. doi: 10.1161/CIRCULATIONAHA.124.068936. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804910/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804910</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068936>10.1161/CIRCULATIONAHA.124.068936</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804910</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Jun-Zhang Chen</dc:creator>
<dc:creator>Yi Liang</dc:creator>
<dc:creator>Bo Liang</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</dc:title>
<dc:identifier>pmid:39804910</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068936</dc:identifier>
</item>
<item>
<title>Recognized Outstanding Reviewers for &lt;em>;Circulation&lt;/em>; in 2024</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804909/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):125. doi: 10.1161/CIRCULATIONAHA.124.073245. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804909/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804909</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073245>10.1161/CIRCULATIONAHA.124.073245</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804909</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Darren K McGuire</dc:creator>
<dc:creator>James A de Lemos</dc:creator>
<dc:creator>Joseph A Hill</dc:creator>
<dc:creator>Circulation Editors Team</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Recognized Outstanding Reviewers for &lt;em>;Circulation&lt;/em>; in 2024</dc:title>
<dc:identifier>pmid:39804909</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073245</dc:identifier>
</item>
<item>
<title>Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Pilot Randomized Controlled Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804908/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):196-198. doi: 10.1161/CIRCULATIONAHA.124.071452. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804908/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804908</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071452>10.1161/CIRCULATIONAHA.124.071452</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804908</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Jinbo Hu</dc:creator>
<dc:creator>Qixin Zhou</dc:creator>
<dc:creator>Yue Sun</dc:creator>
<dc:creator>Zhengping Feng</dc:creator>
<dc:creator>Jun Yang</dc:creator>
<dc:creator>Wenwen He</dc:creator>
<dc:creator>Ying Song</dc:creator>
<dc:creator>Yue Wang</dc:creator>
<dc:creator>Xiangjun Chen</dc:creator>
<dc:creator>Hang Shen</dc:creator>
<dc:creator>Ying Jing</dc:creator>
<dc:creator>Shumin Yang</dc:creator>
<dc:creator>Qifu Li</dc:creator>
<dc:creator>CONPASS Group</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Pilot Randomized Controlled Trial</dc:title>
<dc:identifier>pmid:39804908</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071452</dc:identifier>
</item>
<item>
<title>Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804907/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):129-131. doi: 10.1161/CIRCULATIONAHA.124.068331. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804907/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804907</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068331>10.1161/CIRCULATIONAHA.124.068331</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804907</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Abdul Wahed Sidiqi</dc:creator>
<dc:creator>Diana Dad Zada</dc:creator>
<dc:creator>Nader Ahmad Exeer</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine</dc:title>
<dc:identifier>pmid:39804907</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068331</dc:identifier>
</item>
<item>
<title>Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804906/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):e23. doi: 10.1161/CIRCULATIONAHA.124.071536. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804906/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804906</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071536>10.1161/CIRCULATIONAHA.124.071536</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804906</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Meiyan Sun</dc:creator>
<dc:creator>Shufang He</dc:creator>
<dc:creator>Ji Hu</dc:creator>
<dc:creator>Ye Zhang</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</dc:title>
<dc:identifier>pmid:39804906</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071536</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804905/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):188-192. doi: 10.1161/CIRCULATIONAHA.124.073304. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804905/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804905</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073304>10.1161/CIRCULATIONAHA.124.073304</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804905</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:39804905</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073304</dc:identifier>
</item>
<item>
<title>Swinging Pendulum Between Risks and Benefits of Antiplatelet Agents: A Call for Consistency in the Interpretation of Evidence and Guideline Recommendations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804904/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):126-128. doi: 10.1161/CIRCULATIONAHA.124.070797. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804904/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804904</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070797>10.1161/CIRCULATIONAHA.124.070797</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804904</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Antonio Landi</dc:creator>
<dc:creator>Diana A Gorog</dc:creator>
<dc:creator>Marco Valgimigli</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Swinging Pendulum Between Risks and Benefits of Antiplatelet Agents: A Call for Consistency in the Interpretation of Evidence and Guideline Recommendations</dc:title>
<dc:identifier>pmid:39804904</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070797</dc:identifier>
</item>
<item>
<title>Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804903/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):193-195. doi: 10.1161/CIRCULATIONAHA.124.070509. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804903/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804903</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070509>10.1161/CIRCULATIONAHA.124.070509</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804903</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Tormod Rogne</dc:creator>
<dc:creator>Dipender Gill</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study</dc:title>
<dc:identifier>pmid:39804903</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070509</dc:identifier>
</item>
<item>
<title>Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250115151115&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: An AI model applied to a single ECG image defined the risk of future HF, representing a digital biomarker for stratifying HF risk.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 13:ehae914. doi: 10.1093/eurheartj/ehae914. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Current heart failure (HF) risk stratification strategies require comprehensive clinical evaluation. In this study, artificial intelligence (AI) applied to electrocardiogram (ECG) images was examined as a strategy to predict HF risk.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Across multinational cohorts in the Yale New Haven Health System (YNHHS), UK Biobank (UKB), and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), individuals without baseline HF were followed for the first HF hospitalization. An AI-ECG model that defines cross-sectional left ventricular systolic dysfunction from 12-lead ECG images was used, and its association with incident HF was evaluated. Discrimination was assessed using Harrell's C-statistic. Pooled cohort equations to prevent HF (PCP-HF) were used as a comparator.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 231 285 YNHHS patients, 4472 had primary HF hospitalizations over 4.5 years (inter-quartile range 2.5-6.6). In UKB and ELSA-Brasil, among 42 141 and 13 454 people, 46 and 31 developed HF over 3.1 (2.1-4.5) and 4.2 (3.7-4.5) years. A positive AI-ECG screen portended a 4- to 24-fold higher risk of new-onset HF [age-, sex-adjusted hazard ratio: YNHHS, 3.88 (95% confidence interval 3.63-4.14); UKB, 12.85 (6.87-24.02); ELSA-Brasil, 23.50 (11.09-49.81)]. The association was consistent after accounting for comorbidities and the competing risk of death. Higher probabilities were associated with progressively higher HF risk. Model discrimination was 0.718 in YNHHS, 0.769 in UKB, and 0.810 in ELSA-Brasil. In YNHHS and ELSA-Brasil, incorporating AI-ECG with PCP-HF yielded a significant improvement in discrimination over PCP-HF alone.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: An AI model applied to a single ECG image defined the risk of future HF, representing a digital biomarker for stratifying HF risk.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250115151115&v=2.18.0.post9+e462414">39804243</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae914>10.1093/eurheartj/ehae914</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804243</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Lovedeep S Dhingra</dc:creator>
<dc:creator>Arya Aminorroaya</dc:creator>
<dc:creator>Veer Sangha</dc:creator>
<dc:creator>Aline F Pedroso</dc:creator>
<dc:creator>Folkert W Asselbergs</dc:creator>
<dc:creator>Luisa C C Brant</dc:creator>
<dc:creator>Sandhi M Barreto</dc:creator>
<dc:creator>Antonio Luiz P Ribeiro</dc:creator>
<dc:creator>Harlan M Krumholz</dc:creator>
<dc:creator>Evangelos K Oikonomou</dc:creator>
<dc:creator>Rohan Khera</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study</dc:title>
<dc:identifier>pmid:39804243</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae914</dc:identifier>
</item>





























</channel>
</rss>